Open Label Extension
Sponsors
Bellerophon Pulse Technologies, Scioderm Inc.
Conditions
Inherited connective tissue diseasePulmonary FibrosisPulmonary Hypertension
Phase 3
An Open Label Multi-Center Extension Study to Evaluate the Long-term Safety of Zorblisa
(SD-101-6.0) in Patients with Epidermolysis Bullosa
Active, not recruitingNL-OMON43935
Start: 2015-10-14Target: 14Updated: 2024-02-28
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
TerminatedNCT03267108
Start: 2020-12-14End: 2023-06-30Updated: 2023-07-27